Tags

Type your tag names separated by a space and hit enter

Rhinitis and sinusitis.
J Allergy Clin Immunol. 2010 Feb; 125(2 Suppl 2):S103-15.JA

Abstract

Rhinitis and sinusitis are among the most common medical conditions and are frequently associated. In Western societies an estimated 10% to 25% of the population have allergic rhinitis, with 30 to 60 million persons being affected annually in the United States. It is estimated that sinusitis affects 31 million patients annually in the United States. Both rhinitis and sinusitis can significantly decrease quality of life, aggravate comorbid conditions, and require significant direct medical expenditures. Both conditions also create even greater indirect costs to society by causing lost work and school days and reduced workplace productivity and school learning. Management of allergic rhinitis involves avoidance, many pharmacologic options, and, in appropriately selected patients, allergen immunotherapy. Various types of nonallergic rhinitis are treated with avoidance measures and a more limited repertoire of medications. For purposes of this review, sinusitis and rhinosinusitis are synonymous terms. An acute upper respiratory illness of less than approximately 7 days' duration is most commonly caused by viral illness (viral rhinosinusitis), whereas acute bacterial sinusitis becomes more likely beyond 7 to 10 days. Although the mainstay of management of acute bacterial sinusitis is antibiotics, treatment of chronic sinusitis is less straightforward because only some chronic sinusitis cases have an infectious basis. Chronic rhinosinusitis (CRS) has been subdivided into 3 types, namely CRS without nasal polyps, CRS with nasal polyps, and allergic fungal rhinosinusitis. Depending on the type of CRS present, a variety of medical and surgical approaches might be required.

Authors+Show Affiliations

Allergy and Immunology Unit, Section of Pulmonary, Critical Care Allergy and Immunologic Diseases, Department of Internal Medicine, Center for Human Genomics and Personalized Medicine Research, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA. dykewicz@wfubmc.eduNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

20176255

Citation

Dykewicz, Mark S., and Daniel L. Hamilos. "Rhinitis and Sinusitis." The Journal of Allergy and Clinical Immunology, vol. 125, no. 2 Suppl 2, 2010, pp. S103-15.
Dykewicz MS, Hamilos DL. Rhinitis and sinusitis. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S103-15.
Dykewicz, M. S., & Hamilos, D. L. (2010). Rhinitis and sinusitis. The Journal of Allergy and Clinical Immunology, 125(2 Suppl 2), S103-15. https://doi.org/10.1016/j.jaci.2009.12.989
Dykewicz MS, Hamilos DL. Rhinitis and Sinusitis. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S103-15. PubMed PMID: 20176255.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Rhinitis and sinusitis. AU - Dykewicz,Mark S, AU - Hamilos,Daniel L, PY - 2009/11/02/received PY - 2009/12/30/revised PY - 2009/12/30/accepted PY - 2010/2/24/entrez PY - 2010/3/5/pubmed PY - 2010/4/10/medline SP - S103 EP - 15 JF - The Journal of allergy and clinical immunology JO - J. Allergy Clin. Immunol. VL - 125 IS - 2 Suppl 2 N2 - Rhinitis and sinusitis are among the most common medical conditions and are frequently associated. In Western societies an estimated 10% to 25% of the population have allergic rhinitis, with 30 to 60 million persons being affected annually in the United States. It is estimated that sinusitis affects 31 million patients annually in the United States. Both rhinitis and sinusitis can significantly decrease quality of life, aggravate comorbid conditions, and require significant direct medical expenditures. Both conditions also create even greater indirect costs to society by causing lost work and school days and reduced workplace productivity and school learning. Management of allergic rhinitis involves avoidance, many pharmacologic options, and, in appropriately selected patients, allergen immunotherapy. Various types of nonallergic rhinitis are treated with avoidance measures and a more limited repertoire of medications. For purposes of this review, sinusitis and rhinosinusitis are synonymous terms. An acute upper respiratory illness of less than approximately 7 days' duration is most commonly caused by viral illness (viral rhinosinusitis), whereas acute bacterial sinusitis becomes more likely beyond 7 to 10 days. Although the mainstay of management of acute bacterial sinusitis is antibiotics, treatment of chronic sinusitis is less straightforward because only some chronic sinusitis cases have an infectious basis. Chronic rhinosinusitis (CRS) has been subdivided into 3 types, namely CRS without nasal polyps, CRS with nasal polyps, and allergic fungal rhinosinusitis. Depending on the type of CRS present, a variety of medical and surgical approaches might be required. SN - 1097-6825 UR - https://www.unboundmedicine.com/medline/citation/20176255/Rhinitis_and_sinusitis_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0091-6749(09)02881-4 DB - PRIME DP - Unbound Medicine ER -